Abstract 4119868: Statin and PCSK9 Inhibitor Utilization and Spending in Medicaid between 2018 to 2022: A National Analysis
Circulation
NOVEMBER 11, 2024
Introduction:Low-income working-aged adults in the Medicaid program have a high burden of cardiovascular risk factors and disease, but often face barriers accessing necessary therapies. million statin prescriptions in 2018 compared to 20.3 However, Medicaid spending on statins decreased by 7.1%, from $246.2 million to $226.8
Let's personalize your content